** Shares of Hims & Hers Health HIMS.N slip 3.1% premarket to $50.75 as telehealth firm seeks capital raise

** San Francisco, California-based firm offering privately $450 mln 5-yr convertible bonds

** Co says plans to use net proceeds for general purposes, including accelerating global expansion through organic growth and potential acquisitions

** Portion of net proceeds also to be used to pay for capped calls, derivative transactions employed to offset share dilution

** In other co news, it appointed Mo Elshenawy as chief technology officer. Elshenawy was most recently CTO at Cruise, self-driving vehicle firm owned by General Motors

** With ~223.8 mln shares outstanding, co has ~$11.7 bln market cap, per LSEG data

** On Apr 29, HIMS jumped 23% to close at $35.04 after Denmark's Novo Nordisk NOVOb.CO said it would sell its popular weight-loss drug Wegovy through telehealth firms to cash-paying U.S. customers

** Through Weds close, HIMS has risen nearly 90% over the past month and up 116.5% YTD

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))